The Impact of Syringe Exchange Programs on Hepatitis C in Injection Drug Users

Date
2011
Journal Title
Journal ISSN
Volume Title
Publisher
Producer
Director
Performer
Choreographer
Costume Designer
Music
Videographer
Lighting Designer
Set Designer
Crew Member
Funder
Rehearsal Director
Concert Coordinator
Moderator
Panelist
Alternative Title
Department
CPGC: 2009 Summer Intern, Conferences/Workhops
Haverford College. Independent College Programs
Type
Thesis
Original Format
Running Time
File Format
Place of Publication
Date Span
Copyright Date
Award
Language
eng
Note
Table of Contents
Terms of Use
Rights Holder
Access Restrictions
Bi-College users only
Tripod URL
Identifier
Abstract
This work examines hepatitis C among injection drug users in the United States. Injection drug users are particularly vulnerable to hepatitis C infection because of the efficiency of viral transmission through blood-to-blood contact. I assert that syringe exchange programs, which have been an otherwise highly effective public health intervention, must do more to reduce the burden of hepatitis C on injection drug users. While syringe exchange programs have been successful at reducing the transmission of HIV through encouraging injection drug users to abstain from sharing needles, hepatitis C continues to spread among injection drug users. Original research conducted at Prevention Point of Philadelphia, Philadelphia’s only syringe exchange program, attempted to determine routes of transmission driving the continuing epidemic of hepatitis C among injection drug users. This research also demonstrated that hepatitis C knowledge in the injection drug using community is incomplete, indicating the need for syringe exchange programs to make education about hepatitis C more available to injection drug users. Through an examination of the relationship between hepatitis C, injection drug users, and syringe exchange programs, this thesis argues that syringe exchange programs are uniquely poised to make a significant contribution to the eradication of hepatitis C and the protection of the health of injection drug users.
Description
Citation